ORIC Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
December 05, 2025 20:00 ET | Source: ORIC Pharmaceuticals Highly differentiated 1L…
Virtune AB (Publ) (“Virtune”) has completed the monthly rebalancing for November 2025 of its Virtune Crypto Top 10 Index ETP – the first crypto index ETP in the Nordics
December 05, 2025 05:03 ET | Source: Virtune AB (Publ) Stockholm, 5th…
Symbotic Announces Pricing of Primary and Secondary Offering of Class A Common Stock
December 04, 2025 22:05 ET | Source: Symbotic Inc. WILMINGTON, Mass., Dec.…
Eureka Ergonomic Launches Luxury Leather Office Chair Collection with Holiday Discounts Up to 40%
Los Angeles, CA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- As professionals increasingly…
ORIC Pharmaceuticals Presents Enozertinib Data in NSCLC Patients with HER2 Exon 20 Mutations at the ESMO Asia Congress 2025
December 05, 2025 01:00 ET | Source: ORIC Pharmaceuticals Systemic activity of…
Ipsen provides update on legacy of Henri Beaufour
PARIS, FRANCE, 5 December 2025, Ipsen (Euronext: IPN; ADR: IPSEY) has been informed…
Protara Announces Pricing of $75 Million Public Offering
December 04, 2025 22:03 ET | Source: Protara Therapeutics NEW YORK, Dec.…
uniQure Provides Regulatory Update on AMT-130 for Huntingtons Disease
LEXINGTON, Mass. and AMSTERDAM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- uniQure N.V.…
Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors
December 04, 2025 07:00 ET | Source: Vaxil Bio Ltd. Not for…
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
Topline results from Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected…
